More importantly, previous studies indicate that injecting intraperitoneally FGF21 into mice can significantly attenuate neurodegeneration in mice with diabetes (Kang et al., 2020) and obesity through metabolic modulation and anti-proinflammatory effects (Wang et al., 2018). Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.